References
- IvySPSiuLLGarrett-MayerERubinsteinLApproaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task of national cancer institute investigational drug steering committeeClin Cancer Res20101661726173620215542
- VlahakesGJThe value of phase IV clinical testingN Engl J Med2006354441341516436775
- Wiela-HojeńskaAJaźwińska-TarnawskaEMiędzynarodowe i krajowe systemy monitorowania niepożądanych działań leków – ich rozpoznawanie i zgłaszanieFarm Pol200965725732 Polish
- The WHO Programme for International Drug Monitoring Available from: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/National_PV_Centres_Map/en/Accessed May 26, 2016
- WHO Programme MembersCountries participating in the WHO Programme for International Drug Monitoring, with year of joining Available from: http://www.who-umc.org/DynPage.aspx?id=100653&mn1=7347&mn2=7252&mn3=7322&mn4=7442Accessed June 11, 2016
- Notice of the President of Office for Registration of Medicinal Products, Medical Devices and Biocidal Products of 3 November 2015Zgłoś działanie niepożądane [Report a side effect] Available from: http://www.urpl.gov.pl/pl/produkty-lecznicze/monitorowanie-bezpiecze%C5%84stwa-lek%C3%B3w/zg%C5%82o%C5%9B-dzia%C5%82anie-niepo%C5%BC%C4%85dane-0Accessed October 13, 2016
- Directive of the European Parliament and of the Council 2010/84/EU of 15 December 2010 amending – as regards pharmacovigilance – Directive 2001/83/EC on the Community code relating to medicinal products for human use.
- Drug safety monitoring, Available from: http://www.urpl.gov.pl/pl/produkty-lecznicze/monitorowanie-bezpiecze%C5%84stwa-lek%C3%B3w. Accessed June 11, 2016.
- Acts of 5 December 1996 on the professions of a physician and dentist, as amended (Journal of Laws of 1997 no. 28, item 152).
- Regulation of the Minister of Health of 17 February 2003 on monitoring of the safety of medicinal products (Journal of Laws no. 47, item 405).
- SchetzDSein AnandJPostawy pomorskich lekarzy wobec obowiązku raportowania niepożądanych działań produktów leczniczychPrzegląd Lekarski2015729475478 Polish
- JakubikLPolscy pacjenci rzadko zgłaszają niepożądane działania leków. To może się zmienić Available from: http://www.rynekaptek.pl/prawo/polscy-pacjenci-rzadko-zglaszaja-niepozadane-dzialania-lekow-to-moze-sie-zmienic,5692.htmlAccessed May 26, 2016
- AagaardLHougaardLNHolmeEHConsumer reporting of adverse drug reactions: a retrospective analysis of the Danish adverse drug reaction database from 2004 to 2006Drug Saf200932111067107419810778
- Netherlands Pharmacovigilance Centre (Lareb)Annual Report from Netherlands Pharmacovigilance CentreHertogenboschLareb2005 Available from: www.lareb.nlAccessed May 16, 2016
- de LangenJvan HunselFPassierAde Jong-van den BergLvan GrootheestKAdverse drug reaction reporting by patients in the Netherlands: three years of experienceDrug Saf200831651552418484785
- Health CanadaAdverse Reaction and Medical Device Problem Reporting Available from: http://www.hc-sc.gc.ca/dhp-mps/medeff/report-declaration/index-eng.phpAccessed September 15, 2016
- Food and Drug Administration (FDA)Annual Adverse Drug Experience Report: 1996Silver Spring, MDFDA1997
- KadhimAKSelf-reporting of adverse drug reactions in Iraqi hospitals: patient’s perspectivesPharmacol Pharm20156566572
- GeneraliJADanishMARosenbaumSEKnowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacistsAnn Pharmacother19952943653697633012
- GranasAGBuajordetMStenberg-NilsenHHargPHornAMPharmacists’ attitudes towards the reporting of suspected adverse drug reactions in NorwayPharmacoepidemiol Drug Saf200716442943416953518
- HerdeiroMTFigueirasAPoloniaJGestal-OteroJJInfluence of pharmacists’ attitudes on adverse drug reaction reporting: a case-control study in PortugalDrug Saf200629433134016569082
- LeeAThomasSHLAdverse drug reactionsWalkerRWhitteleCClinical Pharmacy and Therapeutics4th edPeople’s Republic of ChinaChurchill Livingstone2007
- GreenCFMottramDRRowePHPirmohamedMAttitudes and knowledge of hospital pharmacists to adverse drug reaction reportingBr J Clin Pharmacol2001511818611167664
- SweisDWWongICA survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great BritainDrug Saf200023216517210945377
- TokluHZUysalMKThe knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of IstanbulPharm World Sci200830555656218350373
- SuyaghMFarahDFarhaRAPharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting processSaudi Pharm J201523214715325972734
- HerdeiroMTFigueirasAPoloniaJGestal-OteroJJInfluence of pharmacists’ attitudes on adverse drug reaction reporting: a case-control study in PortugalDrug Saf200629433134016569082
- Abdel-LatifMMAbdel-WahabBAKnowledge and awareness of adverse drug reactions and pharmacovigilance practices among health-care professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi ArabiaSaudi Pharm J20152315416125972735